动脉粥样硬化与炎症及药物应用研究进展

被引：16

作者：

张韶辉 ^{[1
]}

高东升 ^{[2
]}

机构：

[1] 天津医科大学

[2] 济宁医学院附属医院心内科

来源：

心血管病学进展 | 2007年 / 06期

关键词：

动脉粥样硬化; 炎症; 药物;

D O I：

暂无

中图分类号：

R543.5 [动脉疾病];

学科分类号：

100201 [内科学];

摘要：

越来越多的资料表明炎症在动脉粥样硬化中扮演重要角色,一些炎症标记物被用来评估动脉粥样硬化患者的临床疗效,在此基础上的大量研究发现降低动脉粥样硬化患者这类炎症标记物的水平能够降低其发生冠脉事件的危险度,这就为动脉粥样硬化的防治提供了新思路。

引用

页码：946 / 951

页数：6

共 10 条

[1]

PERTINENT—PERindopril–Thrombosis; InflammatioN; Endothelial Dysfunction and Neurohormonal Activation Trial: A Sub-Study of the EUROPA Study.[J].Roberto Ferrari.Cardiovascular Drugs and Therapy.2003, 1

[2]

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease:: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study) [J].

Fox, KM ;

Bertrand, M ;

Ferrari, R ;

Remme, WJ ;

Simoons, ML ;

Remme, WJ ;

Simoons, M ;

Bassand, JP ;

Aldershvile, J ;

Hildebrandt, P ;

Bertrand, M ;

Cokkinos, D ;

Toutouzas, P ;

Eha, J ;

Erhardt, L ;

Erikssen, J ;

Grybauskas, P ;

Kalnins, U ;

Karsch, K ;

Sechtem, U ;

Keltai, M ;

Klein, W ;

Lüscher, T ;

Mulcahy, D ;

Nieminen, M ;

Oto, A ;

Ozsaruhan, O ;

Paulus, W ;

Providencia, L ;

Riecansky, I ;

Ruzyllo, W ;

Ferrari, R ;

Santini, U ;

Tavazzi, L ;

Soler-Soler, J ;

Widimsky, P ;

Fox, KM ;

Julian, D ;

Dargie, H ;

Murray, G ;

Kübler, W ;

Thygesen, K ;

Duprez, D ;

Steg, G ;

Drexel, H ;

Gombotz, G ;

Klein, W ;

Duprez, D ;

Heyndrickx, GH ;

Legrand, V .

LANCET, 2003, 362 (9386) :782-788

[3]

Expression of COX-1 and COX-2 mRNAs in atherosclerotic plaques [J].

McGeer, PL ;

McGeer, EG ;

Yasojima, K .

EXPERIMENTAL GERONTOLOGY, 2002, 37 (07) :925-929

[4]

Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS): Additional perspectives on tolerability of long-term treatment with lovastatin [J].

Downs, JR ;

Clearfield, M ;

Tyroler, HA ;

Whitney, EJ ;

Kruyer, W ;

Langendorfer, A ;

Zagrebelsky, V ;

Weis, S ;

Shapiro, DR ;

Beere, PA ;

Gotto, AM .

AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (09) :1074-1079

[5]

Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels [J].

Ridker, PM ;

Rifai, N ;

Pfeffer, MA ;

Sacks, FM ;

Moye, LA ;

Goldman, S ;

Flaker, GC ;

Braunwald, E .

CIRCULATION, 1998, 98 (09) :839-844

[6]

ACE inhibitor quinapril reduces the arterial expression of NF-κB-dependent proinflammatory factors but not of collagen I in a rabbit model of atherosclerosis [J].

Hernández-Presa, MA ;

Bustos, C ;

Ortego, M ;

Tuñón, J ;

Ortega, L ;

Egido, J .

AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (06) :1825-1837

[7]

Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes - A role for CD40 signaling in plaque rupture? [J].

Schonbeck, U ;

Mach, F ;

Sukhova, GK ;

Murphy, C ;

Bonnefoy, JY ;

Fabunmi, RP ;

Libby, P .

CIRCULATION RESEARCH, 1997, 81 (03) :448-454

[8]

阿奇霉素对动脉粥样硬化家兔炎症反应的影响 [J].

张子新 ;

赵卫华 ;

宋丽新 ;

曾定尹 .

中国动脉硬化杂志, 2006, (07) :601-603

[9]

炎性因子对急性冠状动脉综合征的早期预测价值 [J].

张梅 ;

黄体钢 ;

周丽娟 ;

张一芝 ;

张伟函 .

临床心血管病杂志, 2006, (03) :148-151

[10]

阻断CD40-CD40配体系统对动脉粥样硬化的影响 [J].

张峻 ;

陈纪林 ;

顾晴 ;

关婷 ;

陈曦 .

中国动脉硬化杂志 , 2006, (02) :119-122

← 1 →